ESCRS - FP58 - A FRESH APPROACH TOWARDS CORNEAL STROMAL REGENERATION IN ADVANCED KERATOCONUS

A FRESH APPROACH TOWARDS CORNEAL STROMAL REGENERATION IN ADVANCED KERATOCONUS

Published 2024 - 28th ESCRS Winter Meeting

Reference: FP58 | Type: Submission | DOI: 10.82333/wgvg-3e66

Authors: Faruk Semiz* 1 , Njomza Hima Musa 1 , Gamze Tanriverdi 2 , Merjem Purelku 2 , Ceren Ece Semiz 1 , Olcay Semiz 1 , Zekeriya Alp Demirsoy 1 , Gokce Idil Semiz 3 , Nuray BAŞSÜLLÜ 4

1Opthtalmology,Eye Hospital,Pristina,Kosovo, 2Embryology and Histology,Cerrah Pasa Universitesi,Istanbul,Türkiye, 3Medical Faculty,Atilim Universitesi,Ankara,Türkiye, 4Patolog (Hematopatoloji),Bakirkoy Dr. Sadi Konuk Training & Research Hospital Istanbul,Istanbul,Türkiye

Purpose

To demonstrate an increase in vision and central corneal thickness after intrastromal fresh myopic lenticule implantation in advanced keratoconus with the SMiLE module. And to examine both the implanted lenticule with the immunofluorescence method and electron microscopy after lenticule implantation in patients with keratoconus.

Setting

Eye Hospital,Pristina,Kosovo.

Methods

Seventy eyes with advanced keratoconus with corneal transplantation indication were included in this study. Fresh myopic lenticular implants (FML) were placed in all eyes with SMILE surgery. The patients were followed for 4 years. Four years after implantation, lenticular samples from patients were examined under the electron microscope, immunofluorescence, and compared.

Results

The preoperative CDVA improved from 1.42 ± 0.31 logMAR to 0.44 ± 0.06 logMAR (P < .001). The preoperative CCT increased from 334.35 ± 11.24 µm to 477.35 ± 4.31 µm (P < .001). Pieces taken from the lenticule 4 years after lenticular implantation were examined by immunofluorescence method and electron microscopy. Healthy keratocytes and telocyte cells were observed in samples obtained 4 years after lenticular implantation.

Conclusion

In this study is both corneal regeneration and change in corneal shape (Q Value) from conical form to ellipsoid as it contains fresh lenticule stem cells and telocytes. It is intrastromal stem cell therapy. We have proven this with studies of Immunofluorescence, and the electron microscope. Fresh lenticulars have the capacity to activate stromal regeneration and repair damage.
 
(Clinical Trial Registration Number: NCT04591587)